Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat
- 31 December 1996
- journal article
- review article
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 20 (2) , 325-339
- https://doi.org/10.1016/0149-7634(95)00057-7
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the ratJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
- Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1991
- The effect of serotonergic agents on haloperidol-induced catalepsyLife Sciences, 1990
- The PAW test: An animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphismLife Sciences, 1988
- Experimental studies on genetically determined predisposition to catatonia in rats as a model of schizophreniaBehavioural Processes, 1987
- Specific binding of 3H-SCH 23390 to dopamine D1 receptorsLife Sciences, 1986
- Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatumLife Sciences, 1984
- 8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activityJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1982
- Increased amphetamine stereotypy and longer haloperidol catalepsy in spontaneously hypertensive ratsLife Sciences, 1981
- Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressantJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1979